Byrne Asset Management »

Autolus Therapeutics Plc spon ads shares owned by Byrne Asset Management

Quarter-by-quarter ownership of Autolus Therapeutics Plc spon ads (AUTL) shares owned by Byrne Asset Management from 13F filings

Historical chart of Byrne Asset Management investment in Autolus Therapeutics Plc spon ads

Tip: Access up to 7 years of quarterly data

All positions including Autolus Therapeutics Plc spon ads held by Byrne Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Autolus Therapeutics Plc spon ads by Byrne Asset Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $12k 1.8k 6.38
2023-12-31 $18k 2.7k 6.63

More positions owned by Byrne Asset Management

Microsoft Corporation (MSFT)
Apple (AAPL)
Amazon (AMZN)
Google
Johnson & Johnson (JNJ)
Facebook Inc cl a (META)
KKR & Co
JPMorgan Chase & Co. (JPM)
Visa (V)
Lennar Corporation (LEN.B)
Walt Disney Company (DIS)
Toll Brothers (TOL)
Advanced Micro Devices (AMD)
BlackRock Floating Rate Income Strat. Fn (FRA)
NVIDIA Corporation (NVDA)

View all positions for Byrne Asset Management

Top funds holding Autolus Therapeutics Plc spon ads

Syncona Portfolio
Blackstone Group
Paradigm Biocapital Advisors
Polygon Management
Cormorant Asset Management
Frazier Life Sciences Management
T. Rowe Price Associates
Perpetual
Lynx1 Capital Management
Perceptive Advisors
Bank of New York Mellon
Fred Alger Management
Laurion Capital Management
Walleye Trading Advisors
Alphabet

View all funds holding Autolus Therapeutics Plc spon ads